comparemela.com
5
6
7
8
9
10
11
Latest Breaking News On - Mantle cell lymphoma - Page 4 : comparemela.com
Dr Goy on the Rationale for Launching the ZUMA-18 Trial in Relapsed/Refractory MCL
Andre Goy, MD, discusses the evaluation of brexu-cel in the ZUMA-2 and expanded access ZUMA-18 trials in relapsed/refractory mantle cell lymphoma.
United-states
Andre-goy
Hackensack-meridian-health-oncology-care-transformation-services
John-theurer-cancer-center
Lymphoma-division
Hackensack-university-medical-center
John-theurer-cancer-center
Hackensack-university-medical-center
Onclive-tv
Mantle-cell-lymphoma
Current Treatment Options in Third-line MCL
Experts on mantle cell lymphoma discuss third-line treatment options available for patients.
Recent-updates
Follicular-lymphoma
Mantle-cell-lymphoma
Treatment-options
Cmcl
Third-line
Third-line-mcl
Cart-cells
Zuma-2
Brexu-cel
Zuma-2-trial
Sequencing Therapies in the Third-Line and Beyond Setting for MCL
A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.
Recent-updates
Follicular-lymphoma
Mantle-cell-lymphoma
Beyond-setting
Cmcl
Sequencing-therapy
Brexu-cel
Pirtobrutinib
Transplant
Rituximab
Btk-inhibitor
Current Treatment Options in Second-line MCL
Experts on mantle cell lymphoma discuss second-line treatment options available for patients.
Recent-updates
Follicular-lymphoma
Mantle-cell-lymphoma
Treatment-options
Cmcl
Second-line
Dbtk
Acalabrutinib
Zanubrutinib
Spfs
Cart-cell-therapy
Pirtobrutinib Continues to Show Safety, Activity in Covalent BTK Inhibitor–Pretreated R/R MCL
Jonathon B. Cohen, MD, MS, expands on updated data from the BRUIN trial of pirtobrutinib in patients with relapsed BTK-exposed mantle cell lymphoma.
Georgia
United-states
Atlanta
Emory-university
Jonathonb-cohen
Oncology-at-emory-university-school-of-medicine
Lymphoma-program
Department-of-hematology
Safety-monitoring-committee
Winship-cancer-institute
Medical-oncology
vimarsana © 2020. All Rights Reserved.